Graybug Vision Inc (GRAY) News

Graybug Vision Inc (GRAY): $1.27

-0.05 (-3.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter GRAY News Items

GRAY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

GRAY News Highlights

  • GRAY's 30 day story count now stands at 2.
  • Over the past 16 days, the trend for GRAY's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about GRAY are STAR.

Latest GRAY News From Around the Web

Below are the latest news stories about Graybug Vision Inc that investors may wish to consider to help them evaluate GRAY as an investment opportunity.

Graybug Vision (GRAY) Receives a Hold from Leerink Partners

Leerink Partners analyst Marc Goodman maintained a Hold rating on Graybug Vision (GRAY – Research Report) on December 17 and set a price target of $5.00. The company's shares closed last Wednesday at $2.06, close to its 52-week low of $1.79. According to TipRanks.com, Goodman is a 2-star analyst with an average return of 0.1% and a 42.5% success rate. Goodman covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Intra-Cellular Therapies, and Satsuma Pharmaceuticals. Graybug Vision has an analyst consensus of Hold, with a price target consensus of $4.00, which is a 99.0% upside from current levels.

Howard Kim on TipRanks | December 22, 2021

We Think Graybug Vision (NASDAQ:GRAY) Needs To Drive Business Growth Carefully

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | December 6, 2021

Graybug Vision, Inc. (NASDAQ:GRAY) Stake Trimmed by Geode Capital Management LLC

Geode Capital Management LLC cut its holdings in shares of Graybug Vision, Inc. (NASDAQ:GRAY) by 43.0% in the second quarter, HoldingsChannel reports. The fund owned 70,382 shares of the companys stock after selling 52,989 shares during the quarter. Geode Capital Management LLCs holdings in Graybug Vision were worth $382,000 as of its most recent SEC []

Transcript Daily | November 28, 2021

Graybug Vision, Inc. (NASDAQ:GRAY) Stock Position Lifted by Vanguard Group Inc.

Vanguard Group Inc. lifted its holdings in Graybug Vision, Inc. (NASDAQ:GRAY) by 80.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 430,387 shares of the companys stock after purchasing an additional 191,568 shares during the quarter. Vanguard Group Inc. owned 2.04% of Graybug []

Dakota Financial News | November 25, 2021

Graybug Vision, Inc. to Post FY2021 Earnings of ($1.64) Per Share, Wedbush Forecasts (NASDAQ:GRAY)

Graybug Vision, Inc. (NASDAQ:GRAY) – Investment analysts at Wedbush cut their FY2021 earnings per share (EPS) estimates for Graybug Vision in a report issued on Monday, November 15th. Wedbush analyst L. Moussatos now forecasts that the company will post earnings per share of ($1.64) for the year, down from their prior forecast of ($1.57). Wedbush […]

Transcript Daily | November 17, 2021

Graybug Vision to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

BALTIMORE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the conference website beginning at 10 a.m. ET / 7 a.m. PT on November 22, 2021.

Intrado Digital Media | November 15, 2021

Graybug Vision to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

BALTIMORE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the conference website beginning at 10 a.

Yahoo | November 15, 2021

Graybug Vision (NASDAQ:GRAY) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Graybug Vision (NASDAQ:GRAY) announced its earnings results on Thursday. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.37) by ($0.01), MarketWatch Earnings reports. Shares of NASDAQ:GRAY opened at $3.14 on Friday. The company has a 50-day moving average price of $3.43 and a two-hundred day moving average price []

Dakota Financial News | November 14, 2021

Global Ocular Drug Delivery Devices Market to 2027: Leading Players Include Novartis, Allergan, Graybug Vision and Envisia Therapeutics

DUBLIN, Nov. 12, 2021 /PRNewswire/ -- The "Ocular Drug Delivery Devices Market" report has been added to ResearchAndMarkets.com''s offering. The global ocular drug delivery devices market is expected to grow at a CAGR of around 5.3% during 2021-2027. This report on global ocular drug

PR Newswire | November 12, 2021

Graybug Vision Announces Financial Results for the Three and Nine Months Ended September 30, 2021, and Recent Corporate Developments

BALTIMORE, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today provided an update on recent corporate developments and reported financial results for the three and nine months ended September 30, 2021.

Intrado Digital Media | November 11, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5892 seconds.